WhiteFiber (WYFI) surged approximately 47% between mid-June and mid-July 2026, driven by a major AI compute contract, speculative call-option activity, and a Russell index reclassification that repositioned the stock in value-defensive benchmarks. Over the last quarter, the stock gained roughly 126%, reflecting sustained momentum from international expansion, strategic financing moves, and elevated investor appetite for AI infrastructure equities.
Gartner shares closed at $141.31 on July 13, 2026, reflecting a modest 4.6% decline over the trailing 30 days and a significantly steeper 46% year-to-date drop. The company's Q1 2026 earnings surpassed EPS estimates ($3.32 vs. $2.99 consensus), yet revenue of $1.49 billion missed expectations and contracted 1.5% year-over-year.
Applied Digital shares have fallen approximately 32% over the past 30 days, declining from $42.70 on June 12 to $28.84 as of July 13, 2026, underperforming the broader market. The selloff has been driven by escalating concerns over the company's aggressive debt-fueled expansion, customer concentration risk tied to CoreWeave, and persistent GAAP net losses despite robust revenue growth.
IBM shares are down approximately -22.00% in premarket trading, one of the steepest single-session declines in the company's modern history. The primary catalyst is a preliminary second-quarter earnings disclosure that came in well below Wall Street's expectations, particularly in software and consulting revenue.
SHAZ shares tumbled approximately -12.95% during regular trading on Monday to around $64.96, extending a multi-session sell-off from the prior Friday close of $74.62. The decline appears driven by sustained competitive fears following recent reports that Meta is advancing its "Meta Compute" initiative to sell excess AI compute capacity, directly challenging neocloud providers like SharonAI.
PENG is trading down -8.78% during the regular session on July 10, 2026, falling from a previous close of $81.39 to approximately $74.24. The decline follows an explosive two-day rally of over +30% after the company reported blockbuster Q3 earnings on July 7, with EPS of $0.84 beating estimates by 50% and revenue surging 48% year-over-year to $478.7M.
Cognizant Technology Solutions shares fell approximately 17% over the last 30 days, dropping from $53.21 on June 5 to $43.94 on July 7, 2026. The steepest single-day decline occurred on June 18, when the stock plunged 10.49% after industry bellwether Accenture cut its full-year growth outlook and Berenberg downgraded CTSH from Buy to Hold.
Penguin Solutions, Inc. is scheduled to report third quarter fiscal 2026 results after market close on July 7, 2026.
Infosys (INFY) shares have fallen approximately 20.39% over the last 30 days, dropping from $13.41 on June 1 to $10.68, driven by a confluence of sector-wide headwinds and company-specific concerns. The sharpest single-day decline occurred after Accenture trimmed its FY26 revenue growth guidance, triggering a global sell-off in IT services stocks and sending INFY ADRs down nearly 10% in a single session.
CHRN shares plunged -18.67% during Wednesday's regular session, falling from a prior close of $22.23 to $18.08, as investors reacted to a bearish SEC filing. The sell-off was triggered by an 8-K/A filed after the close on June 30, which disclosed carve-out financials for the Cloud business showing a $72.7M net loss in FY2025 and a $32.8M loss for the nine months ended February 2026.
Accenture shares tumbled approximately 36.7% over the last 30 days, driven primarily by a disappointing fiscal third-quarter earnings report and reduced full-year revenue guidance. The stock suffered its worst single-day decline on record on June 18, 2026, plunging roughly 18-20% after the company trimmed its FY2026 growth outlook.
CNXC shares are trading approximately 23% lower in premarket on June 30, 2026, following a severe guidance cut delivered alongside second-quarter earnings. The primary catalyst is a dramatic reduction to full-year fiscal 2026 non-GAAP EPS guidance — lowered to $10.83–$11.18 from a prior analyst consensus of approximately $11.97 — a cut of roughly 9%.
Revenue reached $2.46 billion, up 1.9% year-over-year and within the guided range of $2.46 billion to $2.485 billion. GAAP diluted EPS rose to $0.86 from $0.63 in the prior-year quarter.
CDW shares surged approximately 16% over the last 30 days, rebounding sharply from a post-earnings sell-off that drove the stock to a 52-week low of $97.12 in mid-May. Major Wall Street upgrades from JPMorgan and Morgan Stanley fueled the recovery, with analysts citing attractive valuation and accelerating AI-driven enterprise server demand.
CDW Corporation ( CDW ) shares plunged approximately 19% during the session, closing around $110.80 from a previous close of $136.80. Primary catalyst: Q1 2026 earnings release before market open showed revenue beat ($5.68 billion vs.
APLD shares have traded in a relatively narrow range over the past 30 days, with the stock moving less than 2% as of late June 2026, reflecting a period of consolidation after significant year-to-date gains. The company has secured multiple multibillion-dollar, 15-year hyperscaler lease agreements across five AI factory campuses, pushing total contracted revenue to approximately $36 billion.
Accenture reported third-quarter fiscal 2026 earnings per share of $3.80, beating the consensus estimate of $3.71. Revenue grew year-over-year, supported by demand in consulting and technology services.
Accenture shares are down approximately 16.72% in premarket trading on June 18, 2026, with the stock quoted around $130.09 following the prior regular-session close of $156.21. The primary catalyst is a disappointing Q3 FY2026 revenue miss combined with a meaningful cut to full-year revenue guidance, spooking investors already sensitive to IT spending trends.
Accenture is scheduled to report third-quarter fiscal 2026 results before market open on June 18, 2026. Analysts expect earnings per share of approximately $3.71, up about 6% from the year-ago quarter.
Innodata reported record Q1 2026 results with 54% year-over-year revenue growth, significantly exceeding consensus estimates and prompting raised full-year guidance. Analyst sentiment strengthened with multiple upward revisions to price targets, including Wedbush increasing its target to $120.